Elisabeth Bjork SEC EDGAR Filings (CIK 0001810406)

SEC EDGAR filings, ownership reports, and insider transactions for Elisabeth Bjork.

Business address
C/O Rocket Pharmaceuticals, Inc., 350 Fifth Avenue, Suite 7530, New York, NY, 10116
Top holdings (ownership)
RCKT
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Elisabeth Bjork has filed 11 SEC EDGAR filings since 22 Apr 2020

Latest Filings

Recent SEC filings for Elisabeth Bjork including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 06 Jan 2026 02 Jan 2026 001-36829
4 Open 4 document View SEC filing for 4 FORM 4 27 Aug 2025 27 Aug 2025 001-36829
4 Open 4 document View SEC filing for 4 FORM 4 18 Jul 2025 18 Jun 2025 001-36829
4 Open 4 document View SEC filing for 4 FORM 4 29 Oct 2024 26 Sep 2024 001-36829
4 Open 4 document View SEC filing for 4 FORM 4 20 Jun 2024 13 Jun 2024 001-36829
4 Open 4 document View SEC filing for 4 26 Jun 2023 22 Jun 2023 001-36829
4 Open 4 document View SEC filing for 4 FORM 4 15 Jun 2022 13 Jun 2022 001-36829
4 Open 4 document View SEC filing for 4 FORM 4 16 Jun 2021 14 Jun 2021 001-36829
4 Open 4 document View SEC filing for 4 FORM 4 18 Jun 2020 16 Jun 2020 001-36829
4 Open 4 document View SEC filing for 4 FORM 4 22 Apr 2020 20 Apr 2020 001-36829
3 Open 3 document View SEC filing for 3 FORM 3 22 Apr 2020 20 Apr 2020 001-36829

About this filer

Elisabeth Bjork files with the SEC under CIK 0001810406. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages